O

Ocugen
D

OCGN

0.75840
USD
-0.00
(-0.59%)
Market Open
Volume
8,317
EPS
-0
Div Yield
-
P/E
-4
Market Cap
220,937,300
OverviewSignalsIdeasNews
Related Instruments
    A
    ADVM
    -0.03000
    (-0.67%)
    4.45000 USD
    A
    ALT
    0.04000
    (0.58%)
    6.98000 USD
    BNTX
    BNTX
    3.910
    (3.39%)
    119.240 USD
    C
    CODX
    -0.00880
    (-1.04%)
    0.83900 USD
    I
    INO
    0.03000
    (1.33%)
    2.29000 USD
    MRNA
    MRNA
    1.360
    (3.53%)
    39.850 USD
    N
    NVAX
    -0.01500
    (-0.17%)
    8.83000 USD
    V
    VXRT
    -0.04400
    (-5.41%)
    0.76890 USD
    More
News

Title: Ocugen

Sector: Healthcare
Industry: Biotechnology
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.